NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Jouni Kujala
University of Eastern Finland - Joensuu / Finland
Others
AD Scientific Index ID: 5538934
Itä-Suomen yliopisto
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jouni Kujala's MOST POPULAR ARTICLES
1-)
Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer TumorsJ Kujala, JM Hartikainen, M Tengström, R Sironen, P Auvinen, VM Kosma, ...Cancers 14 (5), 1332, 2022132022
2-)
High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survivalJ Kujala, JM Hartikainen, M Tengström, R Sironen, VM Kosma, ...Cancer Medicine 9 (16), 5922-5931, 2020112020
3-)
High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer SurvivalM Lamminaho, J Kujala, H Peltonen, M Tengström, VM Kosma, ...Cancers 13 (18), 4679, 2021102021
4-)
AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in miceA Kujala, E Valkonen, H Sallinen, L Tuppurainen, H Laakso, ...Frontiers in Medicine 9, 1018208, 20222022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept